16:18 EDT Kiora Pharmaceuticals (KPRX) files $100M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KPRX:
- Kiora Pharmaceuticals Highlights at Ophthalmology Conference
- Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
- Kiora Pharmaceuticals Advances Retinal Disease Pipeline
- Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
- Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright